Urine aquaporin-1 and perilipin-2 may have utility as biomarkers for diagnosing malignant clear cell or papillary renal cell carcinoma (RCC).
Studies suggest that these cholesterol-lowering drugs can improve treatment of genitourinary cancers and prevent contrast-induced nephropathy.
However, researchers stress that losing excess weight can lower the cancer odds.
Patients with these risk factors should be followed up for the rest of their lives, according to the researchers.
Overweight or obese patients treated with targeted therapy for metastatic clear-cell renal cell carcinoma found to live longer.
In a study of 4,736 patients with metastatic renal cell carcinoma, use of the drugs was associated with a nearly 22% decreased risk of death.
Sorafenib or sunitinib given after surgery for advanced renal cell carcinoma does not improve progression-free survival, study shows.
Researchers found elevated familial risks for testicular, prostate, bladder, and kidney cancers.
Risk factors include male gender, distant disease, increasing age, race/ethnicity
Data reveal no significant differences in overall and cancer-specific survival at 5 years.
In a study of post-menopausal women, the highest quartile of lycopene intake was associated with a significant 39% decreased risk of renal cell carcinoma versus the lowest quartile.
98% of the renal tumors were controlled at 9 months after treatment.
Nephron-sparing approach is associated with a 56% decreased risk of postoperative end-stage renal disease versus radical surgery.
Robot-assisted surgery increases access to partial nephrectomy for appropriate patients.
In community practice, overall rate of compliance with AUA Best Practices is less than 60 percent
Low serum albumin levels increase the risk of death in patients undergoing cytoreductive nephrectomy for metastatic renal cell carcinoma.
Medical marijuana may be beneficial for nausea and vomiting, pain and weight loss, but more research is needed to determine potential harms.
New study links statin use with a 52% improvement in 3-year disease-specific survival.
It preserves kidney function better than radical nephrectomy in patients with small- to medium-sized tumors, study finds.
Local anesthesia with conscious sedation for renal cancer cryoablation associated with shorter procedure and hospital stays.
Meta-analysis reveals a significantly increased risk of kidney stones only in male patients with kidney cancer.
A newly-discovered pathway known as Transient Receptor Potential Mleastatin 3 (TRPM3) could provide more treatment options for kidney cancer.
Among surgically-treated renal cell carcinoma patients, diabetics have a 55% and 32% increased risk of cancer-specific and all-cause mortality.
Study shows that tumor flare resulting from discontinuation of sunitinib and pazopanib is associated with decreased overall survival.
Ultrasound surveillance for renal tumors should be performed on native and graft kidneys from 3 years after transplantation.
Patients are 28% more likely to have partial nephrectomy at hospitals offering robotic-assisted surgery.
Are you more likely to perform partial rather than radical nephrectomy for tumors if robotic-assisted surgery is available?September 26, 2014
Availability of robotic-assisted surgery at a hospital was independently associated with greater use of partial nephrectomy.
Are you surprised that targeted therapeutics for metastatic renal cell carcinoma (RCC) have not improved survival?September 12, 2014
A study found that targeted therapeutic agents for treating metastatic RCC has not led to an improvement in survival rates.
In adjusted analyses, female transplant recipients had a significantly increased risk of urologic cancer and men did not.
Study also finds increase in overall cancer rate among African-American children and adolescents.
Sign Up for Free e-newsletters
NEPHROLOGY & UROLOGY NEWS
- Acute Kidney Injury (AKI)
- Chronic Kidney Disease (CKD)
- Contrast Nephropathy
- Cardiovascular Disease (CVD)
- Diabetic Nephropathy
- End-stage Renal Disease (ESRD)
- Lupus Nephritis
- Peritoneal Dialysis
- Secondary Hyperparathyroidism (SHPT)